DENTSPLY SIRONA Files 8-K for Feb 11, 2025

Ticker: XRAY · Form: 8-K · Filed: 2025-02-11T00:00:00.000Z

Sentiment: neutral

Topics: regulatory-filing, 8-K

Related Tickers: XRAY

TL;DR

XRAY files standard 8-K on 2/11/25, no new material news.

AI Summary

DENTSPLY SIRONA Inc. filed an 8-K on February 11, 2025, to report on Regulation FD disclosures and file financial statements and exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for this date.

Why It Matters

This 8-K filing serves as a standard regulatory update for DENTSPLY SIRONA Inc., indicating compliance with reporting obligations without disclosing new material information.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for reporting purposes and does not contain any new material information that would impact the company's risk profile.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for DENTSPLY SIRONA Inc.?

The primary purpose of this 8-K filing is to report on Regulation FD disclosures and to file financial statements and exhibits as of February 11, 2025.

What is the exact date of the earliest event reported in this filing?

The date of the earliest event reported is February 11, 2025.

What is the company's principal executive office address?

The company's principal executive office is located at 13320 Ballantyne Corporate Place, Charlotte, North Carolina 28277-3607.

What is the registrant's telephone number?

The registrant's telephone number is (844) 848-0137.

What is the Standard Industrial Classification (SIC) code for DENTSPLY SIRONA Inc.?

The Standard Industrial Classification (SIC) code for DENTSPLY SIRONA Inc. is 3843, which corresponds to DENTAL EQUIPMENT & SUPPLIES.

From the Filing

0000818479-25-000018.txt : 20250211 0000818479-25-000018.hdr.sgml : 20250211 20250211083304 ACCESSION NUMBER: 0000818479-25-000018 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20250211 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250211 DATE AS OF CHANGE: 20250211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DENTSPLY SIRONA Inc. CENTRAL INDEX KEY: 0000818479 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 391434669 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-16211 FILM NUMBER: 25607773 BUSINESS ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 BUSINESS PHONE: 844-546-3722 MAIL ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 FORMER COMPANY: FORMER CONFORMED NAME: DENTSPLY INTERNATIONAL INC /DE/ DATE OF NAME CHANGE: 19930630 FORMER COMPANY: FORMER CONFORMED NAME: GENDEX CORP DATE OF NAME CHANGE: 19920703 8-K 1 xray-20250211.htm 8-K xray-20250211 0000818479 false 0000818479 2025-02-11 2025-02-11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 February 11, 2025 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 13320 Ballantyne Corporate Place, Charlotte North Carolina 28277-3607 (Address of Principal Executive Offices) (Zip Code) ( 844) 848-0137 (Registrant's telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share XRAY The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 7.01 Regulation FD Disclosure On February 11, 2025, DENTSPLY SIRONA Inc. (the “Company”) issued a press release announcing that it has initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any filing made by

View on Read The Filing